QT Imaging (QTI) Competitors

$5.03 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$5.01 -0.02 (-0.30%)

As of 05/22/2026 04:10 PM Eastern

QTI vs. SMTI, TLSI, STEX, LUCD, and INFU

Should you buy QT Imaging stock or one of its competitors? MarketBeat compares QT Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QT Imaging include Sanara MedTech (SMTI), TriSalus Life Sciences (TLSI), Biosig Technologies (STEX), Lucid Diagnostics (LUCD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.

How does QT Imaging compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 42.0% of Sanara MedTech shares are held by insiders. Comparatively, 28.8% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

QT Imaging has lower revenue, but higher earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$103.12M	2.06	-$37.56M	-$3.77	N/A
QT Imaging	$18.92M	3.20	-$21.08M	-$1.24	N/A

Sanara MedTech has a beta of 1.16, meaning that its stock price is 16% more volatile than the broader market. Comparatively, QT Imaging has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market.

Sanara MedTech currently has a consensus target price of $34.00, suggesting a potential upside of 46.74%. Given Sanara MedTech's higher possible upside, equities research analysts clearly believe Sanara MedTech is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sanara MedTech has a net margin of -31.23% compared to QT Imaging's net margin of -58.93%. Sanara MedTech's return on equity of -3.19% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-31.23%	-3.19%	-0.56%
QT Imaging	-58.93%	-4,220.38%	-51.77%

In the previous week, Sanara MedTech had 3 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Sanara MedTech and 0 mentions for QT Imaging. Sanara MedTech's average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score.

Company	Overall Sentiment
Sanara MedTech	Neutral
QT Imaging	Neutral

Summary

Sanara MedTech beats QT Imaging on 9 of the 14 factors compared between the two stocks.

How does QT Imaging compare to TriSalus Life Sciences?

QT Imaging (NASDAQ:QTI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

QT Imaging has higher earnings, but lower revenue than TriSalus Life Sciences. QT Imaging is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	3.20	-$21.08M	-$1.24	N/A
TriSalus Life Sciences	$45.15M	4.43	-$39.23M	-$1.41	N/A

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 28.8% of QT Imaging shares are held by insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

QT Imaging has a net margin of -58.93% compared to TriSalus Life Sciences' net margin of -60.85%. TriSalus Life Sciences' return on equity of 0.00% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
TriSalus Life Sciences	-60.85%	N/A	-69.91%

In the previous week, TriSalus Life Sciences had 7 more articles in the media than QT Imaging. MarketBeat recorded 7 mentions for TriSalus Life Sciences and 0 mentions for QT Imaging. TriSalus Life Sciences' average media sentiment score of 0.53 beat QT Imaging's score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
QT Imaging	Neutral
TriSalus Life Sciences	Positive

TriSalus Life Sciences has a consensus target price of $7.50, suggesting a potential upside of 130.06%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

QT Imaging has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Summary

TriSalus Life Sciences beats QT Imaging on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Biosig Technologies?

QT Imaging (NASDAQ:QTI) and Biosig Technologies (NASDAQ:STEX) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

QT Imaging has higher revenue and earnings than Biosig Technologies. QT Imaging is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	3.20	-$21.08M	-$1.24	N/A
Biosig Technologies	$40K	5,796.48	-$462.77M	-$9.71	N/A

Biosig Technologies has a consensus price target of $8.00, suggesting a potential upside of 525.00%. Given Biosig Technologies' higher probable upside, analysts clearly believe Biosig Technologies is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Biosig Technologies has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Biosig Technologies' return on equity of -717.92% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
Biosig Technologies	N/A	-717.92%	-336.75%

In the previous week, Biosig Technologies had 5 more articles in the media than QT Imaging. MarketBeat recorded 5 mentions for Biosig Technologies and 0 mentions for QT Imaging. Biosig Technologies' average media sentiment score of 0.49 beat QT Imaging's score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
QT Imaging	Neutral
Biosig Technologies	Neutral

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 52.7% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

QT Imaging has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

Summary

Biosig Technologies beats QT Imaging on 9 of the 14 factors compared between the two stocks.

How does QT Imaging compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Lucid Diagnostics presently has a consensus target price of $4.13, indicating a potential upside of 285.51%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Lucid Diagnostics is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

QT Imaging has higher revenue and earnings than Lucid Diagnostics. QT Imaging is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lucid Diagnostics	$4.71M	46.13	-$58.01M	-$0.47	N/A
QT Imaging	$18.92M	3.20	-$21.08M	-$1.24	N/A

Lucid Diagnostics has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, QT Imaging has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market.

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 6.8% of Lucid Diagnostics shares are owned by insiders. Comparatively, 28.8% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Lucid Diagnostics had 2 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Lucid Diagnostics and 0 mentions for QT Imaging. Lucid Diagnostics' average media sentiment score of 1.96 beat QT Imaging's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Lucid Diagnostics	Very Positive
QT Imaging	Neutral

QT Imaging has a net margin of -58.93% compared to Lucid Diagnostics' net margin of -876.72%. Lucid Diagnostics' return on equity of 0.00% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lucid Diagnostics	-876.72%	N/A	-116.26%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Summary

Lucid Diagnostics beats QT Imaging on 11 of the 16 factors compared between the two stocks.

How does QT Imaging compare to InfuSystem?

InfuSystem (NYSE:INFU) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

InfuSystem presently has a consensus price target of $15.00, indicating a potential upside of 55.28%. Given InfuSystem's stronger consensus rating and higher probable upside, equities research analysts plainly believe InfuSystem is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InfuSystem has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40M	1.37	$870K	$0.38	25.42
QT Imaging	$18.92M	3.20	-$21.08M	-$1.24	N/A

71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by company insiders. Comparatively, 28.8% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, InfuSystem had 3 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for InfuSystem and 0 mentions for QT Imaging. InfuSystem's average media sentiment score of 0.93 beat QT Imaging's score of 0.00 indicating that InfuSystem is being referred to more favorably in the media.

Company	Overall Sentiment
InfuSystem	Positive
QT Imaging	Neutral

InfuSystem has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, QT Imaging has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

InfuSystem has a net margin of 1.12% compared to QT Imaging's net margin of -58.93%. InfuSystem's return on equity of 2.78% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Summary

InfuSystem beats QT Imaging on 14 of the 16 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTI vs. The Competition

Export

Metric	QT Imaging	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$60.57M	$74.43M	$6.46B	$12.34B
Dividend Yield	N/A	N/A	2.76%	5.28%
P/E Ratio	-4.06	8.50	21.00	25.66
Price / Sales	3.20	193.68	562.18	86.31
Price / Cash	N/A	41.36	43.49	56.67
Price / Book	15.72	7.85	10.41	7.14
Net Income	-$21.08M	-$5.50M	$3.57B	$335.98M
7 Day Performance	-4.01%	-5.44%	6.40%	4.11%
1 Month Performance	-22.26%	9.46%	3.54%	2.52%
1 Year Performance	509.70%	177.37%	34.14%	35.04%

QT Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTI QT Imaging	0.4076 of 5 stars	$5.03 flat	N/A	+509.7%	$60.57M	$18.92M	N/A	N/A
SMTI Sanara MedTech	2.1544 of 5 stars	$23.64 +2.8%	$34.00 +43.8%	-23.8%	$216.54M	$103.12M	N/A	60	Gap Up
TLSI TriSalus Life Sciences	3.3683 of 5 stars	$3.45 +6.5%	$7.50 +117.4%	-41.4%	$211.52M	$45.15M	N/A	106	High Trading Volume
STEX Biosig Technologies	2.3313 of 5 stars	$1.13 +3.7%	$8.00 +608.0%	N/A	$204.69M	$40K	N/A	50	Gap Down
LUCD Lucid Diagnostics	4.3729 of 5 stars	$1.00 flat	$4.13 +312.5%	-32.7%	$203.07M	$4.71M	N/A	70

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTI) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Competitors

QTI vs. SMTI, TLSI, STEX, LUCD, and INFU

How does QT Imaging compare to Sanara MedTech?

Summary

How does QT Imaging compare to TriSalus Life Sciences?

Summary

How does QT Imaging compare to Biosig Technologies?

Summary

How does QT Imaging compare to Lucid Diagnostics?

Summary

How does QT Imaging compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Competitors

QTI vs. SMTI, TLSI, STEX, LUCD, and INFU

How does QT Imaging compare to Sanara MedTech?

Do institutionals & insiders hold more shares of SMTI or QTI?

Which has higher valuation & earnings, SMTI or QTI?

Which has more volatility and risk, SMTI or QTI?

Do analysts prefer SMTI or QTI?

Is SMTI or QTI more profitable?

Does the media favor SMTI or QTI?

Summary

How does QT Imaging compare to TriSalus Life Sciences?

Which has stronger earnings & valuation, QTI or TLSI?

Do institutionals and insiders have more ownership in QTI or TLSI?

Is QTI or TLSI more profitable?

Does the media refer more to QTI or TLSI?

Do analysts recommend QTI or TLSI?

Which has more volatility and risk, QTI or TLSI?

Summary

How does QT Imaging compare to Biosig Technologies?

Which has higher valuation and earnings, QTI or STEX?

Do analysts rate QTI or STEX?

Is QTI or STEX more profitable?

Does the media prefer QTI or STEX?

Do insiders and institutionals hold more shares of QTI or STEX?

Which has more risk and volatility, QTI or STEX?

Summary

How does QT Imaging compare to Lucid Diagnostics?

Do analysts rate LUCD or QTI?

Which has higher valuation and earnings, LUCD or QTI?

Which has more risk & volatility, LUCD or QTI?

Do insiders & institutionals have more ownership in LUCD or QTI?

Does the media favor LUCD or QTI?

Is LUCD or QTI more profitable?

Summary

How does QT Imaging compare to InfuSystem?

Do analysts prefer INFU or QTI?

Which has stronger valuation & earnings, INFU or QTI?

Do institutionals and insiders have more ownership in INFU or QTI?

Does the media favor INFU or QTI?

Which has more risk and volatility, INFU or QTI?

Is INFU or QTI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools